Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Nonmedical benzodiazepine use is common among adults with opioid use disorder; however, little is known about this co-occurrence. Anxiety sensitivity--the fear of anxiety symptoms and sensations--motivates behaviors to escape and avoid distressing states, and accordingly is associated with coping motives for substance use. This might be particularly relevant among women, who report using substances to cope with negative emotions more often than men. The aim of the current study was to examine whether nonmedical benzodiazepine use was associated with higher anxiety sensitivity among treatment-seeking adults diagnosed with opioid use disorder, and to investigate whether gender moderated this association. A sample of adults (ranging in age from 18–81 years) receiving inpatient treatment for opioid use disorder (N=257) completed measures of anxiety, anxiety sensitivity, and benzodiazepine use frequency. Results of an analysis of variance indicated that frequency of past-month nonmedical benzodiazepine use was associated with significantly higher anxiety sensitivity. This effect remained when controlling for the effect of anxiety symptoms (F[1, 251] = 3.91, p = .049, ηp2=.02). Gender moderated this association, and post-hoc analyses found a strong association between nonmedical benzodiazepine use and anxiety sensitivity in women, and not men. Anxiety sensitivity, which can be reduced with treatment, might be a candidate therapeutic target in this population, particularly in women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Taylor, S., Zvolensky, M. J., Cox, B. J., Deacon, B., Heimberg, R. G., Ledley, D. R., Abramowitz, J. S., Holaway, R. M., Sandin, B., Stewart, S. H., et al. (2007) · Psychological Assessment · doi:10.1037/1040-3590.19.2.176 · Cited by 1,866 · cited 3×
“The Anxiety Sensitivity Index-3 (ASI-3; Taylor et al., 2007) is a self-report questionnaire used to measure fear of arousal-related sensations.”
BackgroundConway, K. P., Compton, W., Stinson, F. S., & Grant, B. F. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0211 · Cited by 934
Development and validation of an Overall Anxiety Severity and Impairment Scale (OASIS)
Norman, S. B., Hami Cissell, S., Means-Christensen, A. J., & Stein, M. B. (2006) · Depression and Anxiety · doi:10.1002/da.20182 · Cited by 770
Polydrug abuse: a review of opioid and benzodiazepine combination use
Jones, J. D., Mogali, S., & Comer, S. D. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.07.004 · Cited by 703
Park, T. W., Saitz, R., Ganoczy, D., Ilgen, M. A., & Bohnert, A. S. B. (2015) · BMJ · doi:10.1136/bmj.h2698 · Cited by 579
Campbell-Sills, L., Norman, S. B., Craske, M. G., Sullivan, G., Lang, A. J., Chavira, D. A., Bystritsky, A., Sherbourne, C., Roy-Byrne, P., & Stein, M. B. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.014 · Cited by 382
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.10.1485 · Cited by 263 · cited 1×
“Cognitive-behavioral therapy targeting anxiety sensitivity increases the likelihood of successful benzodiazepine taper among those with anxiety disorders (Otto et al., 2010; Otto et al., 1993).”
BackgroundDimensions of anxiety sensitivity in the anxiety disorders: evaluation of the ASI-3
Wheaton, M. G., Deacon, B. J., McGrath, P. B., Berman, N. C., & Abramowitz, J. S. (2012) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2012.01.002 · Cited by 245
Development and initial evaluation of the Brief Addiction Monitor (BAM)
Cacciola, J. S., Alterman, A. I., DePhilippis, D., Drapkin, M. L., Valadez, C., Fala, N. C., Oslin, D., & McKay, J. R. (2013) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2012.07.013 · Cited by 203 · cited 2×
“Nonmedical benzodiazepine use in the month prior to hospitalization was assessed using the Brief Addiction Monitor (BAM; Cacciola et al., 2013), a 17-item self-report measure of substance use severity.”
BackgroundMethodSmits, J. A. J., Powers, M. B., Cho, Y., & Telch, M. J. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.4.646 · Cited by 203
Cited by
The epidemiology of benzodiazepine misuse: A systematic review*
Votaw, V. R., Geyer, R., Rieselbach, M. M., & McHugh, R. K. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.02.033 · Cited by 479
Self-citationCavicchioli, M., Movalli, M., Vassena, G., Ramella, P., Prudenziati, F., & Maffei, C. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2019.106035 · Cited by 94
Affective vulnerability in substance use disorders
McHugh, R. K., & Kneeland, E. T. (2019) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2019.01.011 · Cited by 80
Self-citationComorbidity of opioid-related and anxiety-related symptoms and disorders
Langdon, K. J., Dove, K., & Ramsey, S. (2019) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2018.12.020 · Cited by 53
Sex differences in benzodiazepine misuse among adults with substance use disorders
McHugh, R. K., Geyer, R. B., Chase, A. R., Griffin, M. L., Bogunovic, O., & Weiss, R. D. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106608 · Cited by 51
Self-citation
Metadata
- Authors
- McHugh, R. K., Votaw, V. R., Bogunovic, O., Karakula, S. L., Griffin, M. L., & Weiss, R. D.
- Venue
- Addictive Behaviors
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 65
- Pages
- 283-288
- ISSN
- 0306-4603 (ISSN-L)
- OpenAlex
- W2510513160
- Cited by
- 64
- References
- 14
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder. https://app.cochat.ai/papers/10.1016/j.addbeh.2016.08.020
- The paper
- McHugh, R. K., Votaw, V. R., Bogunovic, O., Karakula, S. L., Griffin, M. L., & Weiss, R. D. (2017). Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder. Addictive Behaviors. https://doi.org/10.1016/j.addbeh.2016.08.020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.